Oncotarget | Selective Protection of Normal Cells From Chemotherapy, While Killing Drug-Resistant Cancer Cells
March 13, 2023
PRESS RELEASE: On March 11, 2023, Dr. Blagosklonny published a new review in Oncotarget, entitled, “Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells.” continue reading »